Laboratories will have direct access to Colaborate’s consulting expertise, combined with the reliability and reach of Henry Schein’s network and lab capabilities. 

A recent federal court ruling overturned the FDA’s authority to regulate LDTs, immediately impacting lab operations across the country.

We play a necessary role in the process by providing subject matter expertise aimed at minimizing risk and maximizing the probability of a successful outcome.